|
Estradiol Ultrasensitive
ESTRAULTRA
Synonyms
|
|
Allscripts (AEHR) Order Name
|
Estradiol, Ultrasensitive, LC/MS/MS
|
Sunrise Clinical Manager (SCM) Order Name
|
Estradiol Ultrasensitive
|
EPIC Order Name
|
.Estradiol Ultrasensitive by Mass Spectrometry
|
Clinical Info
|
Recommended for clinical situations in which increased sensitivity of E2 levels is appropriate, including postmenopausal women, men, and children and adolescents
|
Specimen Type
|
Blood
|
Container
|
Red Top Tube
|
Collection Instructions
|
Container/Tube: Red top tube or Gold top Tube
Specimen: 1.0 mL serum (0.6 mL min)
Transport Temperature: Refrigerated
Stability: 14 Days Room Temperature, Refrigerated or Frozen
|
Transport Instructions
|
Refrigerated
|
Specimen Stability
|
14 Days Room Temperature, Refrigerated or Frozen
|
Methodology
|
Liquid chromatography/tandem mass spectrometry (LC/MS-MS)
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared by the Food and
Drug Administration.
|
Days Performed
|
|
Performing Laboratory
|
LabCorp
|
CPT
|
82670
LOINC Code: 35384-7
|
PDM
|
5960055
|
Result Interpretation
Newborn: Levels are markedly elevated at birth
and fall rapidly during the first week to prepubertal levels
<15.0 pg/mL.
1 to 6 months: Male: Levels increase to
10.0−32.0 pg/mL between 30 and 60 days, then decline to
prepubertal levels <15.0 pg/mL by six months.
1 to 11 months: Female: Levels increase to
5.0−50.0 pg/mL between 30 and 60 days, then decline to
prepubertal levels <15.0 pg/mL by the first year.
Prepubertal children:
• Male (6 months to 10 years): <15.0
• Female (1 to 9 years): <15.0
Puberty: See table.
Tanner Stage
|
Male
|
1
|
Age (y)
|
<9.8
|
Range (pg/mL)
|
5.0−11.0
|
Mean (pg/mL)
|
8.0
|
2
|
Age (y)
|
9.8−14.5
|
Range (pg/mL)
|
5.0−16.0
|
Mean (pg/mL)
|
11.0
|
3
|
Age (y)
|
10.7−15.4
|
Range (pg/mL)
|
5.0−25.0
|
Mean (pg/mL)
|
16.0
|
4
|
Age (y)
|
11.8−16.2
|
Range (pg/mL)
|
10.0−36.0
|
Mean (pg/mL)
|
22.0
|
5
|
Age (y)
|
12.8−17.3
|
Range (pg/mL)
|
10.0−36.0
|
Mean (pg/mL)
|
21.0
|
Female
|
1
|
Age (y)
|
<9.2
|
Range (pg/mL)
|
5.0−20.0
|
Mean (pg/mL)
|
8.0
|
2
|
Age (y)
|
9.2−13.7
|
Range (pg/mL)
|
10.0−24.0
|
Mean (pg/mL)
|
16.0
|
3
|
Age (y)
|
10.0−14.4
|
Range (pg/mL)
|
7.0−60.0
|
Mean (pg/mL)
|
25.0
|
4
|
Age (y)
|
10.7−15.6
|
Range (pg/mL)
|
21.0−85.0
|
Mean (pg/mL)
|
47.0
|
5
|
Age (y)
|
11.8−18.6
|
Range (pg/mL)
|
34.0−170.0
|
Mean (pg/mL)
|
110.0
|
Adults
|
Age (y)
|
Range (pg/mL)
|
Male
|
Age (y)
|
8.0−35.0
|
Female
|
Follicular
|
Age (y)
|
30.0−100.0
|
Luteal
|
Age (y)
|
70.0−300.0
|
Postmenopausal
|
Age (y)
|
<15.0
|
Tanner Stage
|
Age (y)
|
Range (pg/mL)
|
Mean (pg/mL)
|
Male
|
1
|
<9.8
|
5.0−11.0
|
8.0
|
2
|
9.8−14.5
|
5.0−16.0
|
11.0
|
3
|
10.7−15.4
|
5.0−25.0
|
16.0
|
4
|
11.8−16.2
|
10.0−36.0
|
22.0
|
5
|
12.8−17.3
|
10.0−36.0
|
21.0
|
Female
|
1
|
<9.2
|
5.0−20.0
|
8.0
|
2
|
9.2−13.7
|
10.0−24.0
|
16.0
|
3
|
10.0−14.4
|
7.0−60.0
|
25.0
|
4
|
10.7−15.6
|
21.0−85.0
|
47.0
|
5
|
11.8−18.6
|
34.0−170.0
|
110.0
|
Adults
|
Range (pg/mL)
|
Male
|
8.0−35.0
|
Female
|
Follicular
|
30.0−100.0
|
Luteal
|
70.0−300.0
|
Postmenopausal
|
<15.0
|
|
Forms
|
|
|